We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Biotronik has agreed to pay almost $13 million to settle allegations that it paid kickbacks to physicians to encourage their use of the company’s implantable cardiac devices. Read More
The FDA announced Friday that remote regulatory assessments (RRA) have proven to be a valuable tool and the agency will continue to use them beyond the COVID-19 pandemic. Read More
In a final guidance released on Friday, the FDA said it will enforce standard date formatting and Unique Device Identification (UDI) labeling requirements for certain class I and unclassified devices starting on Dec. 8. Read More
QuadM Technologies received a Form 483 from the FDA after an inspection of its Hamilton, N.J., facility in April that highlighted a variety of documentation issues. Read More
Failure to ensure that its medical devices met regulatory and other requirements landed Health Care Technology (HCT) a Form 483 from the FDA following an inspection at its Ashland, Mass. facility in April. Read More
The Department of Justice (DOJ) has launched a nationwide law enforcement action against fraudulent billing for cardiovascular and cancer genetic tests and medical devices. Read More
Florida-based drug developer Transpire Bio has teamed up with Sweden’s Recipharm to develop inhaled medicines for treating asthma and chronic obstructive pulmonary disease (COPD). Read More